Skip to main content

Closed

IMTX: Immatics N.V. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+188.6% / yr

Operating margin-570.3%

ROIC-43.1%

Financially safe

Stretched

Debt / equity0.03×

Interest coverage-234.0×

Current ratio8.78×

Immatics N.V.

IMTXNASDAQ Capital Market·USD·Closed

Immatics N.V.

IMTXNASDAQ·USD·Closed

$8.66

−5.87%

$8.66

−$0.54 (5.87%)

52W Range

49thpctl

Volume

0.40×avg

Mkt Cap

1.16BUSD

P/E

-4.4TTM

Div Yield

–ann

52W Range

49thpctl

Volume

0.40×avg

Market Cap

1.16BUSD

P/E Ratio

-4.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings